Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Kaps

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Advanced Healthcare Materials|December 3, 2015
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel ParticlesLeonard Kaps, Lutz Nuhn, Misbah Aslam, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
BMC Gastroenterology|February 5, 2025
Collagen turnover biomarkers to predict outcome of patients with biliary cancerLeonard Kaps, Muhammed A Genc, Markus Moehler, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
International Journal of Molecular Sciences|March 6, 2021
New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma CellsEva Schaller, Andi Ma, Lisa Chiara Gosch, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Advanced Healthcare Materials|December 3, 2015
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel ParticlesLeonard Kaps, Lutz Nuhn, Misbah Aslam, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
BMC Gastroenterology|February 5, 2025
Collagen turnover biomarkers to predict outcome of patients with biliary cancerLeonard Kaps, Muhammed A Genc, Markus Moehler, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
International Journal of Molecular Sciences|March 6, 2021
New 3-Aryl-2-(2-thienyl)acrylonitriles with High Activity Against Hepatoma CellsEva Schaller, Andi Ma, Lisa Chiara Gosch, et al.
Pageof 7